DKK-1 is a potent inhibitor of the Wnt signaling pathway that can modulate immune cell activities, promote tumor growth in mouse models of prostate cancer, and is a promising target for cancer immunotherapy (Thudi et al. Here, DKK1 is linked to Familial prostate cancer.